Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 145-149

  Peyromaure, Michaël ^a   Badoual, Cécile ^b   Camparo, Philippe ^c   Grabar, Sophie ^a   Goulvestre, Claire ^a   Fulla, Yvonne ^a   Vieillefond, Annick ^a   Mao, Kaili ^a   Dinh Xuan, Anh Tuan ^a  

^a Institut Cochin   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c University of Paris Descartes   (France)

Author keywords

Angiogenesis; Prostate cancer; Vascular endothelial growth factor

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ARTICLE; BLOOD; DISEASE COURSE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; TISSUE MICROARRAY;

AGED; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548052033     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.1.145     Document Type: Article

References (15)

1. Hicklin DJ and Ellis LM: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23: 1001-1027, 2005.
2. Soulitzis N, Karyotis I, Delakas D and Spandidos DA: Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int J Oncol 29: 305-314, 2006.
3. Koul D, Shen R, Garyali A, Ke LD, Liu TJ and Yung WK: MMAC/PTEN suppressor gene regulates vascular endothelial growth-factor mediated angiogenesis in prostate cancer. Int J Oncol 31: 469-475, 2002.
4. Duque JL, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D and Freeman MR: Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology 54: 523-527, 1999. (Pubitemid 29407032)
5. Shariat SF, Anwuri VA, Lamb DJ, Shah NV, Wheeler TM and Slawin KM: Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy. J Clin Oncol 22: 1655-1663, 2004. (Pubitemid 41079804)
6. Walsh K, Sherwood RA, Dew TK and Mulvin D: Angiogenic peptides in prostatic disease. BJU Int 84: 1081-1083, 1999.
7. George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ and Kantoff PW: Cancer and Leukemia Group B 9480: Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. Clin Cancer Res 7: 1932-1936, 2001. (Pubitemid 32994827)
8. Kanda S, Miyata Y and Kanetake H: Current status and perspective of antoangiogenic therapy for cancer: urinary cancer. Int J Oncol 11: 90-107, 2006.
9. Ma ZS, Huynh TH, Ng CP, Do PT, Nguyen TH and Huynh H: Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and celluler proliferation. Int J Oncol 24: 1297-1304, 2004.
10. Peyromaure M, Goulvestre C, Fulla Y, Grabar S, Debre B and Dinh-Xuan AT: Serum levels of vascular endothelial growth factor in patients undergoing prostate biopsies for suspicion of prostate cancer. Urology 66: 687-691, 2005. (Pubitemid 41242361)
11. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C and Selby PJ: Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956-964, 1998. (Pubitemid 28101786)
12. George DJ, Regan MM, Oh WK, Tay MH, Manola J, Decalo N, Duggan S, Dewolf WC, Kantoff PW and Bubley GJ: Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer. Urology 63: 327-332, 2004. (Pubitemid 38234429)
13. Li R, Younes M, Wheeler TM, Scardino P, Ohori M, Frolov A and Ayala G: Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate 58: 193-199, 2004. (Pubitemid 38160907)
14. Jennbacken K, Vallbo C, Wang W and Damber JE: Expression of vascular endothelial growth factor C (VEGF-C) and VEGF Receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate 65: 110-116, 2005. (Pubitemid 41362277)
15. Galper SL, Chen MH, Catalona WJ, Roehl KA, Richie JP and D'Amico AV: Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol 175: 907-912, 2006. (Pubitemid 43200015)